{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T04:01:26Z","timestamp":1751774486057,"version":"3.41.0"},"reference-count":42,"publisher":"Japanese Association of Rural Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rural Med"],"published-print":{"date-parts":[[2025]]},"DOI":"10.2185\/jrm.2024-050","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T22:13:06Z","timestamp":1751321586000},"page":"233-237","source":"Crossref","is-referenced-by-count":0,"title":["Incidental diagnosis of Fabry disease by detecting mulberry bodies in a          Bangladeshi male with infertility and residing in Japan: a case report highlighting          clinical and economic challenges"],"prefix":"10.2185","volume":"20","author":[{"given":"Kosuke","family":"Kojo","sequence":"first","affiliation":[{"name":"Department of Urology, Institute of Medicine, University of Tsukuba,              Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Mase","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Institute of Medicine, University of Tsukuba,              Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisato","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Institute of Medicine, University of              Tsukuba, Japan"},{"name":"Center for Medical Genetics, Keio University School of Medicine,              Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Arita","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Institute of Medicine, University of              Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Division of Laboratory, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Medicine, University of Tsukuba,              Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Institute of Medicine, University              of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"995","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sanchez-Ni\u00f1o              MD, Sanz              AB, Carrasco              S, et al.            Globotriaosylsphingosine actions on human glomerular podocytes:            implications for Fabry nephropathy. Nephrol Dial            Transplant          2011; 26: 1797\u20131802.","DOI":"10.1093\/ndt\/gfq306"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Germain              DP. Fabry            disease. Orphanet J Rare Dis          2010; 5: 30.","DOI":"10.1186\/1750-1172-5-30"},{"key":"3","unstructured":"3. Houge              G, Skarb\u00f8vik              AJ. [Fabry            disease\u2014a diagnostic and therapeutic challenge]. Tidsskr Nor            Laegeforen          2005; 125: 1004\u20131006 (in          Norwegian)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Saeed              S, Imazio              M. Fabry            disease in South and Central Asia: is it truly a rare disease or            underappreciated?Pak J Med Sci          2022; 38: 2373\u20132375.","DOI":"10.12669\/pjms.38.8.7064"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Selvarajah              M, Nicholls              K, Hewitson              TD, et al.            Targeted urine microscopy in Anderson\u2013Fabry disease: a cheap, sensitive            and specific diagnostic technique. Nephrol Dial            Transplant          2011; 26: 3195\u20133202.","DOI":"10.1093\/ndt\/gfr084"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Palecek              T, Honzikova              J, Poupetova              H, et al.            Prevalence of Fabry disease in male patients with unexplained left            ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy            screening study (FACSS). J Inherit Metab Dis          2014; 37: 455\u2013460.","DOI":"10.1007\/s10545-013-9659-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Battaglia              Y, Scalia              S, Rinaldi              R, et al.            Identification of new \u03b1-galactosidase A mutation responsible for Fabry            disease: a case report. Clin Nephrol          2019; 91: 126\u2013128.","DOI":"10.5414\/CN109501"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lin              Z, Zhang              X, Liu              Y, et al.            Screening for Fabry disease in patients with left ventricular hypertrophy            in China: a multicentre and prospective study. ESC Heart            Fail          2024; 11: 4381\u20134389.","DOI":"10.1002\/ehf2.15065"},{"key":"9","unstructured":"9. Ministry of Health, Labour and            Welfare of Japan, Overview of orphan drug\/medical device designation          system, 2009.          https:\/\/www.mhlw.go.jp\/english\/policy\/health-medical\/pharmaceuticals\/orphan_drug.html.          Accessed September 22, 2024."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kanatani              Y, Tomita              N, Sato              Y, et al.            National Registry of Designated Intractable Diseases in Japan: present            status and future prospects. Neurol Med Chir (Tokyo)          2017; 57: 1\u20137.","DOI":"10.2176\/nmc.st.2016-0135"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Uchida              T, Takahashi              Y, Yamashita              H, et al.            Evaluation of clinical practice guidelines for rare diseases in            Japan. JMA J          2022; 5: 460\u2013470.","DOI":"10.31662\/jmaj.2022-0094"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ureshino              H, Kamachi              K, Kimura              S. Japan\u2019s            high-cost medical expense benefit system could be an obstacle to promoting generic            imatinib. Lancet Haematol          2019; 6: e498.","DOI":"10.1016\/S2352-3026(19)30168-1"},{"key":"13","unstructured":"13. World Bank. World          development indicators: Bangladesh. The World Bank Group, Washington DC,          2024. https:\/\/data.worldbank.org\/country\/bangladesh. Accessed September 22,          2024."},{"key":"14","unstructured":"14. Ministry of Labour and Social            Policies. The Bangladeshi community in Italy: migrant population annual          report executive summary. Ministry of Labour and Social Policies, Rome, 2023.          https:\/\/integrazionemigranti.gov.it\/AnteprimaPDF.aspx?id=6179. Accessed September 22,          2024."},{"key":"15","unstructured":"15. Immigration Services Agency of            Japan. [Number of foreign residents as of the end of June, 2023. Chapter          1: Number of foreign residents. Table 1: Trends in the number of foreign residents by          nationality\/region]. Ministry of Justice, Tokyo, 2023; (in Japanese).          https:\/\/www.moj.go.jp\/isa\/content\/001403955.pdf. Accessed September 22,          2024."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Oder              D, Nordbeck              P, Wanner              C. Long term            treatment with enzyme replacement therapy in patients with Fabry          disease. Nephron          2016; 134: 30\u201336.","DOI":"10.1159\/000448968"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nagao              S, Satoh              N, Inaba              S, et al.            Concentric lamellar spheres in urine from a female carrier of and            patients with Fabry\u2019s disease\u2014with special reference to polarization and electron            microscopic comparison with nephrotic syndrome. J            Dermatol          1985; 12: 70\u201378.","DOI":"10.1111\/j.1346-8138.1985.tb01540.x"},{"key":"18","unstructured":"18. Miyawaki              M, Hirano              A, Umeda              M, et al.            [Late-onset Fabry disease diagnosed by the detection of urinary mulberry            cells during medical check-up]. Ningen Dock          2020; 35: 210\u2013216 (in          Japanese, Abstract in English)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Papaxanthos-Roche              A, Demini\u00e8re              C, Bauduer              F, et al.            Azoospermia as a new feature of Fabry disease.            Fertil Steril          2007; 88: 212.e15\u2013212.e18.","DOI":"10.1016\/j.fertnstert.2006.11.036"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sansone              L, Barreca              F, Belli              M, et al.            Infertility in Fabry\u2019s disease: role of hypoxia and inflammation in            determining testicular damage. Front Endocrinol            (Lausanne)          2024; 15: 1340188.","DOI":"10.3389\/fendo.2024.1412673"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Papaxanthos-Roche              A, Maillard              A,                Chansel-Debordeaux              L, et al.            Semen and male genital tract characteristics of patients with Fabry            disease: the FERTIFABRY multicentre observational study. Basic            Clin Androl          2019; 29: 7.","DOI":"10.1186\/s12610-019-0088-4"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yumura              Y, Tsujimura              A, Imamoto              T, et al.            Nationwide survey of urological specialists regarding male infertility:            results from a 2015 questionnaire in Japan. Reprod Med            Biol          2017; 17: 44\u201351.","DOI":"10.1002\/rmb2.12065"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Punab              M, Poolamets              O, Paju              P, et al.            Causes of male infertility: a 9-year prospective monocentre study on 1737            patients with reduced total sperm counts. Hum Reprod          2017; 32: 18\u201331.","DOI":"10.1093\/humrep\/dew284"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Katsigianni              EI, Petrou              P. A systematic            review of economic evaluations of enzyme replacement therapy in Lysosomal storage            diseases. Cost Eff Resour Alloc          2022; 20: 51.","DOI":"10.1186\/s12962-022-00369-w"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Jovanovic              A,                Miller-Hodges              E, Castriota              F, et al.            A systematic literature review on the health-related quality of life and            economic burden of Fabry disease. Orphanet J Rare Dis          2024; 19: 181.","DOI":"10.1186\/s13023-024-03131-y"},{"key":"26","unstructured":"26. Research Group on Improving the            Acceptance Environment for Foreign Patients (Lead Researcher: Kitagawa Y).          [Section 11: Advance presentation of estimated medical costs]. In: [Materials from the 7th          meeting on medical services for foreign visitors to Japan (held by circulation) (document          4-1): manual for medical institutions on accepting foreign patients]. Ministry of Health,          Labour and Welfare, Tokyo, 2019; 37\u201339 (in Japanese).          https:\/\/www.mhlw.go.jp\/content\/10800000\/000601513.pdf#page=37. Accessed September 22,          2024."},{"key":"27","unstructured":"27. United Nations Department of            Economic and Social Affairs. Graduation of Bangladesh, Lao People\u2019s          Democratic Republic and Nepal from the LDC category. United Nations, New York,            2021.          https:\/\/www.un.org\/development\/desa\/dpad\/2021\/graduation-of-bangladesh-lao-peoples-democratic-republic-and-nepal-from-the-ldc-category\/.          Accessed September 22, 2024."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Mhatre              SP, Muranjan              M, Gogtay              NJ. Economic            burden of Gaucher disease at a tertiary care public hospital in Mumbai.            Indian J Pediatr          2024; 91: 463\u2013469.","DOI":"10.1007\/s12098-023-04740-4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Gupta              N, Endrakanti              M. Economic            evaluation of rare disease therapies in India\u2014the time has            come!Indian J Pediatr          2024; 91: 432\u2013433.","DOI":"10.1007\/s12098-024-05062-9"},{"key":"30","unstructured":"30. Japan Medical Education            Foundation. High-cost medical expense benefit (Eligibility Certificate for          Ceiling-Amount Application) or KOGAKU RYOYOHI SEIDO (GENDOGAKU TEKIYO NINTEISHO). Ministry          of Health, Labour and Welfare, Tokyo, 2018.          https:\/\/www.mhlw.go.jp\/seisakunitsuite\/bunya\/kenkou_iryou\/iryou\/kokusai\/setsumeisiryo\/dl\/en09.pdf.          Accessed September 22, 2024."},{"key":"31","unstructured":"31. Public Relations Office            JHIA. Gifu Branch, When you are required to pay high medical          expenses\u2014high-cost medical expense benefit\u2014. Japan Health Insurance Association, Gifu,            2021.          https:\/\/www.kyoukaikenpo.or.jp\/~\/media\/Files\/gifu\/kohosi\/eigo\/kougakue.pdf. Accessed          September 22, 2024."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Dake              S. [Foreign workers and policy          issues in social security]. Nihon R\u014dd\u014d Kenky\u016b Zasshi 2022; 744: 55\u201365 (in          Japanese, Abstract in English).","DOI":"10.4009\/jsdt.55.65"},{"key":"33","unstructured":"33. Ministry of Health, Labour and            Welfare of Japan, Intractable disease measures. Ministry of Health, Labour          and Welfare, Tokyo, 2011.          https:\/\/www.mhlw.go.jp\/english\/wp\/wp-hw5\/dl\/23010223e.pdf. Accessed September 22,          2024."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Supakul              S,                Jaroongjittanusonti              P,                Jiaranaisilawong              P, et al.            Access to healthcare services among Thai Immigrants in Japan: a study of            the areas surrounding Tokyo. Int J Environ Res Public            Health          2023; 20: 6290.","DOI":"10.3390\/ijerph20136290"},{"key":"35","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1186\/s12889-023-16107-7","volume":"23","year":"2023","unstructured":"35. Paudel              S, K C                Bhandari              A, Gilmour              S, et al.            Barriers and facilitating factors to healthcare accessibility among            Nepalese migrants during COVID-19 crisis in Japan: an exploratory sequential mixed            methods study. BMC Public Health          2023; 23: 1226.","journal-title":"BMC Public Health","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2458","issn-type":"print"},{"key":"36","unstructured":"36. Sugie              Y, Kodama              T. Immigrant health issue in          Japan\u2014the global contexts and a local response to the issue\u2014. J\u014dsai Kokusai Daigaku Kiy\u014d          (Josai Int Univ Bull) 2014; 22: 1\u201322."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Rombach              SM, Hollak              CE, Linthorst              GE, et al.            Cost-effectiveness of enzyme replacement therapy for Fabry            disease. Orphanet J Rare Dis          2013; 8: 29.","DOI":"10.1186\/1750-1172-8-29"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Matsuda              S. Health            Policy in Japan\u2014current situation and future challenges. JMA            J          2019; 2: 1\u201310.","DOI":"10.31662\/jmaj.2018-0016"},{"key":"39","unstructured":"39. Jones              RS. Health-care reform in          Japan: Controlling costs, improving quality and ensuring equity. In: OECD Economics          Department Working Papers No 739. OECD Publishing, Paris, 2009. ISBN: NA."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Inoue              S, Kobayashi              M, Pang              F. An economic            evaluation of migalastat versus ERT for the treatment of Fabry disease in            Japan. Value Health          2018; 21 .","DOI":"10.1016\/j.jval.2018.07.832"},{"key":"41","unstructured":"41. Solidarity Network with Migrants            Japan. [Statement: Protest against reports and investigations regarding          foreign nationals\u2019 enrollment in medical insurance]. Solidarity Network with Migrants          Japan, Tokyo, 2018; (in Japanese).          https:\/\/migrants.jp\/news\/voice\/20180803_2.html. Accessed September 22, 2024."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Takura              T. Study Group            Research on Appropriate Medical Treatment Prices for Foreigners Visiting            Japan.Preliminary examination of an appropriate price            calculation method and medical treatment costs for foreign visitors in            Japan. Int J Environ Res Public Health          2021; 18: 5837.","DOI":"10.3390\/ijerph18115837"}],"container-title":["Journal of Rural Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jrm\/20\/3\/20_2024-050\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T04:49:15Z","timestamp":1751690955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jrm\/20\/3\/20_2024-050\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2185\/jrm.2024-050","relation":{},"ISSN":["1880-487X","1880-4888"],"issn-type":[{"type":"print","value":"1880-487X"},{"type":"electronic","value":"1880-4888"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2024-050"}}